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In comparison to murine dendritic cells (DCs), less is
known about the function of human DCs in tissues.
Here, we analyzed, by using lung tissues from
humans and humanized mice, the role of human
CD1c+ and CD141+ DCs in determining the type of
CD8+ T cell immunity generated to live-attenuated
influenza virus (LAIV) vaccine. We found that both
lung DC subsets acquired influenza antigens in vivo
and expanded specific cytotoxic CD8+ T cells
in vitro. However, lung-tissue-resident CD1c+ DCs,
but not CD141+ DCs, were able to drive CD103
expression on CD8+ T cells and promoted CD8+
Tcell accumulation in lungepithelia invitroand invivo.
CD1c+ DCs induction of CD103 expression was
dependent on membrane-bound cytokine TGF-b1.
Thus, CD1c+ and CD141+ DCs generate CD8+ T cells
with different properties, and CD1c+ DCs specialize
in the regulation of mucosal CD8+ T cells.
INTRODUCTION
Dendritic cells (DCs) are key regulators of innate and adaptive
immune responses (Banchereau and Steinman, 1998). DCs are
very efficient and can elicit T cell responses at much lower
DC:T cell ratios than other antigen-presenting cells (APC) such
as macrophages (Steinman, 2011). Tissue-resident DCs refer
to those DCs that are present in normal noninflamed tissues.
Recent studies in the mouse have established that tissue-
resident DCs arise from two distinct lineages, the Batf3, IRF8,
Id2-dependent and Batf3, IRF8, Id2-independent lineage
(Edelson et al., 2010; Ginhoux et al., 2009; Hashimoto et al.,
2011; Hildner et al., 2008). These studies also established that
Batf3, IRF8, Id2-dependent DCs, which include both lymphoid-
tissue-resident CD8+ DCs and non-lymphoid-tissue-resident818 Immunity 38, 818–830, April 18, 2013 ª2013 Elsevier Inc.CD103+ DCs, have a superior ability to drive CD8+ T cell immune
responses compared to CD8 and CD103 DCs (Heath and
Carbone, 2009). Considerably less is known about the origin of
human DCs, their differentiation program, and their functional
differentiation in situ due to their rarity in the blood and poor
accessibility of human tissues. Most of the studies that probed
the specialization of human DC subsets have focused on
blood-circulating and skin DCs (reviewed in Ueno et al., 2010).
These studies have distinguished human-blood-circulating DC
subsets based on three main cell-surface markers: CD303
(BDCA-2) on plasmacytoid DCs (pDCs), CD1c (or BDCA-1)
expressed on the majority of circulating DCs, and CD141 (or
BDCA-3) expressed on a minute population (Dzionek et al.,
2000; MacDonald et al., 2002). These markers were also utilized
to establish the presence of DC subsets in the human lung
(Demedts et al., 2005). Human CD141+CD1c DCs were found
to uniquely express Toll-like receptor 3 (TLR3); they excel in
the production of interleukin-12 (IL-12) and the cross-presenta-
tion to CD8+ T effector cells when activated with poly I:C
(Bachem et al., 2010; Crozat et al., 2010; Haniffa et al., 2012;
Jongbloed et al., 2010; Lauterbach et al., 2010; Mittag et al.,
2011; Poulin et al., 2010). However, other human DCs such as
epidermal Langerhans cells (LCs) (Klechevsky et al., 2008,
2010) and CD1c+ DCswere also found to cross-present antigens
to CD8+ T cells (Jongbloed et al., 2010; Mittag et al., 2011; Poulin
et al., 2010). Skin LCs’ efficiency in priming naive CD8+
T cells can be at least partially explained by their surface ex-
pression of IL-15 (Banchereau et al., 2012; Romano et al.,
2012) and/or upregulation of CD70 upon viral exposure (van
der Aar et al., 2011). Yet, upon exposure to some viruses, LCs
are unable to generate CD8+ T cell immunity (van der Vlist
et al., 2011). Thus, it remains to be determined how and via which
mechanisms all of these DC subsets cooperate in shaping
adaptive immunity.
To assess the role of human respiratory mucosal DCs in
vaccine immunity in vivo, we reconstituted immunodeficient
mice with human CD34+ hematopoietic progenitor cells
(HPCs). A few weeks after transplant, mice generate human
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Figure 1. Human CD1c+ and CD141+ DC Subsets in the Lung
Single-cell suspensions from lung tissues obtained from human subjects (A and B) or humanized mice (C and D) were stained with specific Abs and analyzed by
flow cytometry. (A) and (C) show that DCs were gated as CD45+, CD3, CD19, CD4+, HLA-DR+, CD14 and CD11c+ cells with differential expression of CD1c
and CD141. Flow cytomtery characterization of surface marker expression relative to a fluorescence-minus-one (FMO) control on CD1c+ and CD141+ DCs
obtained from human lungs (B) or from the lungs of humanized mice (D). One of three experiments is shown. See also Figure S1.
Immunity
CD1c+ DCs Expand Mucosal CD8+ T CellsB cells and all human DC subsets including pDCs and classical
DCs (cDCs) in the bone marrow and spleen as well as cDCs in
peripheral tissues (Palucka et al., 2003; Yu et al., 2008). In one
version of the model, human T cells were adoptively transferred,
thereby permitting the analysis of T cell subsets and memory
T cell responses. These humanized mice, when vaccinated
with live attenuated influenza vaccine (LAIV), generated CD8+
T cells specific to influenza matrix protein 1 (FluM1) and
nonstructural protein 1 (NS1) in blood, spleen, and lungs. The
expansion of antigen-specific CD8+ T cells is dependent on the
reconstitution of the human myeloid compartment (Yu et al.,
2008). Therefore, we used these mice and human lung tissues
herein to analyze the role of human lung CD1c+ and CD141+
DC subsets in the induction of anti-viral CD8+ T cell responses.
Here we show that whereas both DC subsets could acquire viral
antigens and drive antiviral effector CD8+ T cell responses,
CD1c+ DCs were uniquely able to drive the differentiation of
CD103+CD8+ mucosal T cells.RESULTS
Characterization of CD1c+ and CD141+ DCs in Lungs
Wefirst characterized the distribution of CD1c+ andCD141+ DCs
in human lungs and in the lungs of humanized mice in the steady
state. Human lung samples were obtained during surgical resec-
tion in patients with lung cancer as macroscopically uninvolved
normal tissue. DCs were analyzed by using flow cytometry by
gating on CD45+CD4+HLA-DR+CD11c+CD14 cells (as shown
in Figure 1 and Figure S1 and O’Doherty et al., 1993) with differ-
ential expression of CD1c and CD141 (Figure 1A). Single-cell
suspensions of human lungs contained CD1c+ DCs (n = 8:
mean ± SD = 62% ± 8.7%, range = 48%–72%) and CD141+
DCs (mean ± SD = 20% ± 10%, range = 11%–41%). Both DC
subsets displayed expression of major histocompatibility com-
plex (MHC) class I and histocompatibility leukocyte antigen
(HLA)-DR, as well as costimulatory molecules CD40, CD80,
and CD86. CD1c+ DCs displayed a higher expression of HLA-DRImmunity 38, 818–830, April 18, 2013 ª2013 Elsevier Inc. 819
Immunity
CD1c+ DCs Expand Mucosal CD8+ T Cellsand CD86 (Figure 1B). Immunofluorescence on frozen sections
showed CD1c+ DCs in close proximity to cytokeratin-expressing
epithelial cells whereas CLEC9A-expressing CD141+ DCs
(Jongbloed et al., 2010) were found predominantly in the intersti-
tium (Figure S1F). To facilitate functional studies of lung DC sub-
sets, we next analyzed their reconstitution in vivo in the lungs of
humanized mice. Sublethally irradiated NOD-SCID B2m/mice
were transplanted with 3 3 106 CD34+ HPCs isolated from
G-CSF-mobilized blood of HLA-A*0201+ healthy donors (Yu
et al., 2008). Flow cytometry analysis on single-cell suspensions
from lungs 4–6 weeks later showed the presence of CD1c+ DCs
(n = 7: mean ± SD = 63% ± 6.4%, range = 55%–69%) and
CD141+ DCs (mean ± SD = 25% ± 6.7%, range = 20%–36%)
at ratios comparable to those in human lungs (Figure 1C).
CD141+ DCs expressed higher amounts of MHC class I and
CD40 and lower amounts of CD86 (Figure 1D). Upregulation of
CD80 expression on DCs from human lungs might be ascribed
to lengthy ex vivo isolation procedures. Thus, the distribution
and phenotype of CD1c+ and CD141+ DC subsets in the lungs
of humanized mice are comparable to that of human lungs.
CD1c+ and CD141+ DCs Can Expand Influenza-Specific
Memory CD8+ T Cells
To define the role of lung CD1c+ and CD141+ DCs in the
differentiation of CD8+ T cells, humanized mice were inoculated
intranasally with LAIV because this route allows expansion of
FluM1-specific CD8+ T cell numbers both in blood and lungs
(Yu et al., 2008). Both DC subsets could be detected in lungs
and draining lymph nodes (LNs) at day 3 post inoculation (Fig-
ures 2A and 2B; Figures S2A–S2D). Then, DCs were sorted
from the lungs, spleen, and draining LNs and cocultured with
CFSE-labeled autologous total T cells for 8 days without exoge-
nous cytokines. Expansion of antigen-specific CD8+ T cells
ex vivo was defined as the percentage of CFSE-negative
CD3+CD8+ T cells that bound FluM1-peptide-loaded HLA-
A*0201 tetramer by flow cytometry (Figures 2C–2F). T cells
cultured with either purified lung CD1c+ or CD141+ DCs showed
comparable expansion of FluM1-tetramer+ CD8+ T cells at
different DC:T cell ratios (Figures 2C and 2D) and CFSE dilutions
(Figure S2E). Similarly, the two DC subsets sorted from draining
LNs induced comparable expansion of FluM1-tetramer-binding
CD8+ T cells in vitro (Figures 2E and 2F). The ability of both
CD1c+ and CD141+ DC subsets to capture and present influenza
antigens to memory T cells was further confirmed by using DC
subsets sorted from the lungs of humanized mice and loaded
with LAIV in vitro (Figure S2F). These results show that CD1c+
and CD141+ DCs can capture vaccine antigens both in vivo
and in vitro. They can also present these antigens to CD8+
T cells, resulting in the expansion of FluM1-specific recall T cell
responses. Thus, both CD1c+ and CD141+ DCs can contribute
to the generation of CD8+ T cell immunity against influenza virus.
CD1c+ DCs Induce the Differentiation of CD103+CD8+
T Cells
To further probe the functions of these two DC subsets, we
assessed their capacity to induce allogeneic naive CD8+ T cell
responses. To this end, titrated numbers of CD1c+ DCs and
CD141+ DCs sorted from lungs, draining LNs, and spleens of
humanized mice inoculated with LAIV and from the lungs and820 Immunity 38, 818–830, April 18, 2013 ª2013 Elsevier Inc.blood of human subjects were cocultured with CFSE-labeled,
allogeneic, naive T cells for 6 days. CD8+ T cells cultured with
CD141+ DCs from the lungs of humanized mice proliferated
more than those cultured with CD1c+ DCs at all DC doses
(mean: 21% versus 42% for 1K DCs, p < 0.0001; 6.5% versus
33% for 500 DCs, p < 0.0001; 6.1% versus 20% for 250 DCs,
p < 0.01, of CFSE-negative CD8+ T cells, respectively;
p < 0.0001; Figures S3A and S3B). Similar results were observed
with DCs sorted from human lungs (mean: 22% versus 10% for
1K DCs, p < 0.01; 15% versus 5.7% for 500 DCs, p < 0.01, of
CFSE-negative CD8+ T cells, respectively; Figure S3C). These
results suggest that CD141+ DCs are more efficient in initiating
naive CD8+ T cell proliferation, both in the steady state (human
lungs) and after viral challenge (humanized mice).
These results prompted us to further examine whether these
two distinct DC subsets would allow the generation of CD8+
T cells of different phenotype and function. Thus, we used a large
panel of cell-surface antibodies to identify mucosal markers
differentially expressed by CD8+ T cells educated by CD1c+ or
CD141+ DCs. Naive allogeneic CD8+ T cells cocultured with
CD1c+ DCs purified from humanized mice lungs showed signif-
icantly higher expression of the aE integrin (CD103) (mean ± SD =
25 ± 11%, range = 9.8%–51%, n = 18 for CD1c+ DCs versus
mean ± SD = 4.2 ± 3.3%, range = 0.5%–12%, n = 18 for
CD141+ DCs, p < 0.0001; Figures 3A and 3B). CD103 is known
to promote T cell retention inmucosa (Cepek et al., 1994). Similar
to humanized mice, CD1c+ DCs purified from human lungs were
also superior to CD141+ DCs at eliciting CD103 expression on
allogeneic CD8+ T cells (mean ± SD = 33 ± 12%, range =
13%–51%, n = 12 versus mean ± SD = 6.8 ± 5.6%, range =
1.0%–20%, n = 13, respectively; p < 0.0001; Figures 3C and
3D). The differential induction of CD103 on CD8+ T cells was
also observed with DC subsets purified from the spleen of
humanized mice (Figures S3D and S3E) and from human blood
(mean ± SD = 28 ± 14%, range = 15%–53%, n = 6 for CD1c+
DCs versus mean ± SD = 2.6 ± 2.1%, range = 0.7%–5.5%, n =
6 for CD141+ DCs, p = 0.0014; Figures 3E and 3F). Kinetic
studies showed that the CD103 induction on allogeneic CD8+
T cells was linked with T cell proliferation appearing at day 4 of
coculture (Figure S3F). This suggests that the induction of
CD103 expression is dependent on cognate interactions as pre-
viously proposed (Glader et al., 2005).
Experiments performed with autologous influenza-antigen-
specific T cells yielded similar results. Whereas both CD1c+ and
CD141+ DCs exposed to LAIV expanded autologous CD8+
T cells (Figure 3G), the frequency of CD103-expressing CD8+
T cells was significantly higher in cocultures with CD1c+ DCs
(mean ± SD = 25 ± 9.4%, range = 4.2%–33%, n = 10 versus
mean ± SD = 3.7 ± 2.3%, range = 0%–7.4%, n = 10, p < 0.0001;
Figure 3H). Moreover, CD103+CD8+ T cells educated by blood
CD1c+ DCs expressed VLA-1, NKG2D, but lacked NKG2A (Fig-
ure S3G). Kinetic experiments indicated that the expression of
CD103 on autologous antigen-specific CD8+ T cells was induced
around day 6 of coculture (Figure S3H). To determine whether
CD1c+ DCs’ superior ability to expand CD103+CD8+ T cells
reflects their ability to induce the differentiation of CD103
T cells into CD103+ T cells, or rather drive the proliferation of ex-
istingCD103+CD8+ T cells, purifiedCD103 T cellswere exposed
to autologous human blood DCs. As shown in Figure S3I, CD1c+
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Figure 2. Generation of Influenza-Specific Recall T Cell Responses by CD1c+ and CD141+ Lung DC Subsets
(A and B) Flow cytometry analysis of CD1c+ and CD141+ DCs isolated from the lungs (A) and draining LNs (dLNs) (B) of humanized mice before and 3 days after
LAIV inoculation. One of three experiments is shown.
(C–F) Humanized mice were inoculated intranasally with PBS or LAIV. Three days later, CD1c+CD141 and CD1cCD141+DC subsets were purified from the
lungs and dLNs, coculturedwith autologous T cells for 8 days, and the expansion of specific CD8+ T cells wasmeasured by using FluM1-tetramer. Dot plots show
the percentage of FluM1-specific CD8+ T cells upon coculture with DC subsets sorted from the lungs (C) or dLNs (E) of PBS- (upper plots) and LAIV- (lower plots)
inoculated humanized mice. (D) and (F) show the percentages of FluM1 tetramer+ CD8+ T cells (ordinate) obtained upon coculture with titrated doses of CD1c+
(red) and CD141+ (blue) DCs isolated from the lungs (D) or dLNs (F). n = 2 experiments from eight different mice cohorts. See also Figure S2.
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Figure 3. CD1c+ DCs Elicit the Differentia-
tion of CD103+ CD8+ T Cells
CD1c+ and CD141+ DCs were sorted from lungs of
humanized mice after LAIV inoculation (A and B),
human lungs (C and D), and human blood (E–I).
(A–F) Sorted DCs were cocultured with 105 CFSE-
labeled allogeneic naive T cells for 6 days. T cell
proliferation was measured by CFSE dilution and
CD103 expression in CSFE-negative CD8+ T cells.
(A), (C), and (E) show representative dot plots
illustrating the phenotype of proliferating-gated
CFSE-negative CD8+ T cells in cocultures with
CD1c+ and CD141+ DC subsets isolated from
different tissues. (B), (D), and (F) show summaries
of data from more than five experiments per each
condition.
(G–I) A similar experiment was carried out with
autologous T cells by using CD1c+ and CD141+
DC subsets sorted from the blood and loaded
with LAIV ex vivo. T cell proliferation and
CD103 expression were assessed on proliferating
CFSECD8+ T cells and tetramer-positive cells to
FluM1 or NS1 epitopes at day 8. One of five ex-
periments is shown. See also Figure S3.
Immunity
CD1c+ DCs Expand Mucosal CD8+ T CellsDCs were uniquely able to induce CD103 expression on CD103
CD8+ T cells. Furthermore, CD1c+ DCswere also uniquely able to
drive the differentiation of autologous CD103+ FluM1 and NS1-
specific CD8+ T cells from HLA-A*0201 donors (Figure 3I). Thus,
CD1c+ DCs have a unique capacity to induce CD103 expression
in both naive and memory CD8+ T cells.822 Immunity 38, 818–830, April 18, 2013 ª2013 Elsevier Inc.CD103+CD8+ T Cells Elicited by
CD1c+ DCs Bind E-Cadherin and
Express an Effector Phenotype
Both CD1c+ and CD141+ DCs isolated
from the lungs of LAIV-inoculated
humanized mice and cocultured with
allogeneic naive T cells were able to
expand CD8+ T cells expressing gran-
zyme B (Figure S4A). Similarly, prolifer-
ating CFSECD8+ T cells expanded by
allogeneic LAIV-loaded human blood
DC subsets also displayed a cytotoxic
phenotype expressing both granzyme
A, granzyme B, and perforin (Figure S4B).
Furthermore, as illustrated in Figure S4C,
CD8+ T cells expanded ex vivo by LAIV-
loaded blood DC subsets recognized
and killed T2 targets pulsed with FluM1
peptide even at very low E:T ratios. As
T2 cells do not express E-cadherin,
adherence of CD8+ T cells to target cells
via CD103 cannot modulate their cyto-
toxic activity thereby allowing us to
compare the TCR-dependent lytic activ-
ity of CD8+ T cells elicited by the two
DC subsets. These results show that
CD8+ T cells elicited by both CD1c+
and CD141+ DCs display comparable
lytic activity in vitro, which is consistentwith their comparable intensity of FluM1 tetramer staining
(Figure 2) and their comparable levels of effector molecule
expression.
Through binding to E-cadherin, CD103 integrins control
effector and memory T cell retention in epithelial compartments
(Cepek et al., 1994). To assess whether T cells educated by the
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Figure 4. CD103+CD8+ T Cells Expanded by
CD1c+ DCs Show Features of Mucosal
Lymphocytes
CD1c+ and CD141+ DCs were purified from the
lungs of humanized mice after LAIV inoculation
(A and B) and from human lungs (C and D) and
cocultured with allogeneic naive T cells. At day 6 of
coculture, proliferating CFSE CD8+ T cells were
sorted and further labeled with CFSE for Stamper-
Woodruff assays on human lung sections.
(A) T cells from cocultures with different DC sub-
sets were overlaid on human lung-tissue sections,
and after 1 hr of incubation, the sections were
washed and counterstained with cytokeratin.
T cells were identified by CFSE (green), and airway
epithelium was identified as cytokeratin+ (red,
scale bar represents 100 mm).
(B and C) The numbers of T cells bound to lung
airway epithelium locations were quantified in
0.1 mm2 cytokeratin+ areas. Two experiments are
shown using T cells elicited by CD1c+ and CD141+
DCs from the lungs of humanized mice (B) and
from human lungs of two different donors (C).
(D) Proliferating CFSE CD8+ T cells sorted from
cocultures with human lung CD1c+ DCs were
pretreated with anti-CD103 Abs or isotype control
prior to performing the Stamper-Woodruff assay
as described above. Two-tailed t test was used for
statistical analysis. See also Figure S4.
Immunity
CD1c+ DCs Expand Mucosal CD8+ T CellsCD1c+ DC subset have a superior ability to adhere to epithelial
cells, we used a modified Stamper-Woodruff tissue-binding
assay (Bell et al., 1999). Proliferating CFSE-negative allogeneic
CD8+ T cells were sorted from cocultures with DC subsets, re-
labeled with CFSE and overlaid on frozen lung tissue sections
to allow adherence. After one-hour incubation, tissue sections
were washed and counter-stained with anti-cytokeratin mAbs
to visualize the epithelial sections (Figure 4A). The numbers of
T cells bound to the lung epithelium were quantified inImmunity 38, 818–80.1 mm2 cytokeratin+ areas by using a
series of consecutive tissue sections.
T cells isolated from cocultures with
CD1c+ DCs from the lungs of humanized
mice (Figure 4B) or from human lungs
(Figure 4C) bound at much higher
numbers to the frozen lung tissue sec-
tions. Blockade of CD103 on T cells
resulted in a significant decrease in the
number of CD8+ T cells bound to
lung tissue sections (Figure 4D). These
results show that CD1c+ DCs expand
CD8+ T cells with increased adherence
to lung tissue in a CD103-dependent
manner.
CD1c+ DCs Elicit the Accumulation
of CD103+CD8+ T Cells In Vivo
To assess whether T cells educated by
CD1c+ DCs have a superior ability to
accumulate in human epithelial compart-
ments in vivo, we established a humanepithelial environment by engrafting immunodeficient animals
with human E-cadherin+ HLA-A*0201+ lung-epithelia-derived
cell lines and assessed T cell accumulation in these epithelial
compartments upon adoptive transfer in vivo.
Proliferating CFSE-negative HLA-A*0201+CD8+ T cells puri-
fied from cocultures with allogeneic CD1c+ or CD141+ DCs
loaded with LAIV were relabeled with CFSE and injected directly
into human epithelial grafts in mice. Three days later, only T cells
that were expanded by CD1c+ DCs remained in the human30, April 18, 2013 ª2013 Elsevier Inc. 823
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Figure 5. CD1c+ DCs Elicit the Differentia-
tion of CD103+CD8+ T Cells In Vivo
(A and B) CD1c+ and CD141+ DCs were purified
from human blood and cocultured with allogeneic
naive CFSE-labeled CD8+ T cells. Proliferating
CFSE CD8+ T cells cultured with either CD1c+ or
CD141+ DCs were sorted and further labeled with
CFSE. CFSE-relabeled T cells (1 3 105 cells) were
injected into the human epithelial grafts and
single-cell suspensions were analyzed by flow
cytometry at day 3. Dot plots show the presence
of CD8+CFSE+ T cells. (B) Anti-CD103 or isotype
control Abs (50 mg) were given daily to block T cell
binding.
(C) CD1c+ and CD141+ DC subsets sorted from
human blood were coinjected with allogeneic
naive CFSE-labeled T cells (3 3 105 DCs and
3 3 106 T cells) into human epithelial environ-
ments. Human epithelia were harvested 6 days
later and analyzed by flow cytometry. Dot plots
show the presence of CD3+CD8+ human T cells
(upper plots) and the percentages of CFSE-
negative CD103+ cells in gated CD3+CD8+ T cells
(lower plots). One of two experiments is shown.
See also Figure S5.
Immunity
CD1c+ DCs Expand Mucosal CD8+ T Cellsepithelial grafts (Figure 5A). The retention of CD1c+ DC-educated
T cells was dependent on CD103 as daily treatment with anti-
CD103 but not with isotype control antibody abolished T cell
retention in human epithelial grafts in vivo (Figure 5B). Further-
more, CD1c+ DC-educated T cells retained CFSE labeling,
indicating their lack of proliferation (Figure 5B). These results
suggest that the superior ability of T cells educated by the
CD1c+ DC subset to accumulate in epithelial sites is not due to
a higher proliferation potential but rather to an increased adher-
ence to the epithelial sites.
Next, we determine whether CD1c+ DCs can elicit the differ-
entiation of CD103+CD8+ T cells directly at the epithelial site
in vivo. To this end, immunodeficient mice engrafted with824 Immunity 38, 818–830, April 18, 2013 ª2013 Elsevier Inc.human E-cadherin+ epithelial compart-
ments were injected with human blood
CD1c+ or CD141+ DCs and CFSE-
labeled allogeneic naive T cells. Sub-
stantially higher percentages of T cells
were present in human lung epithelial
grafts reconstituted with CD1c+ DCs
compared to lung epithelial grafts recon-
stituted with CD141+ DCs (Figure 5C). A
majority of T cells adoptively transferred
into epithelial compartments reconsti-
tuted with CD1c+ DCs had lost CFSE
labeling, indicating that they had prolifer-
ated in vivo and acquired CD103 ex-
pression (Figure 5C). The differential
accumulation of T cells in human
epithelia reconstituted with CD141+ or
CD1c+ DCs was not due to differential
survival because the same numbers of
T cells were present in the spleen of
these mice (Figure S5). Thus, theseresults establish that CD1c+ DCs play a critical role in the gen-
eration and maintenance of epithelial CD103+CD8+ T cells
in vivo.
CD1c+ DCs Elicit CD103+CD8+ T Cells via TGF-b
Granulocyte macrophage colony stimulating factor (GM-CSF)
has been shown to control CD103 expression and enhance
cross-presentation function in murine DCs (Edelson et al.,
2011; Zhan et al., 2011). However, GM-CSF blockade did not
affect the ability of CD1c+ DCs to induce CD103 expression on
CD8+ T cells in vitro (Figure S6). TGF-b1 controls CD103 expres-
sion on T cells inmice and humans (Parker et al., 1992; Rihs et al.,
1996). Accordingly, flow cytometry analysis of blood DC subsets
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Figure 6. TGF-b Expression in CD1c+ DCs
(A and B) Histogram represents membrane-bound TGF-b1 expression (red) and isotype control (black) in DC subsets isolated from human blood (A). Mean
fluorescence intensity of TGF-b1 expression in gated human blood CD1c+ and CD141+ DCs from three different donors (B).
(C) Immunofluorescence staining of TGF-b1 (green) on sorted human blood CD1c+ DCs (left panel) or CD141+ DCs (middle panel) and isotype control (green, right
panel). Cells are defined by DAPI staining (blue) and phase contrast (gray). Scale bar represents 10 mm.
(D) TGF-b related gene expression. Transcript intensity values are normalized to the median of all samples including DC subsets from human blood (HB), spleen
(HMS), and lungs (HML) of humanized mouse and from human lungs (HL). Red transcripts are relatively overabundant and blue transcripts underabundant.
(E) Histograms represent surface expression of TGF-b RI, TGF-b RII, CD36, and PLAUR on CD1c+ DCs and CD141+ DCs present in human blood, the lungs of
humanized mice, and human lungs. One of two experiments is shown. See also Figure S6.
Immunity
CD1c+ DCs Expand Mucosal CD8+ T Cellsreproducibly showed that CD1c+ but not CD141+ DCs displayed
membrane TGF-b1 expression (Figures 6A and 6B). This was
further confirmed by confocal microscopy analysis (Figure 6C).
To further analyze the contribution of TGF-b1 to CD1c+ DC-
mediated regulation of CD103 in CD8+ T cells, we analyzed
transcriptional profiles of CD1c+ and CD141+ DCs sorted from
human blood and lungs and from humanized mouse spleens
and lungs at the steady state. As illustrated in Figure 6D, both
DC subsets in all analyzed tissues displayed similar abundance
of TGFB1 and TGFB1 receptor transcripts. Thus, both DC sub-
sets in all analyzed tissues expressed TGF-b receptors by flow
cytometry analysis (Figure 6E). These results suggested that
CD1c+ DCsmight be equipped with molecular machinery, allow-
ing the binding and activation of latent TGF-b1. Indeed, CD1c+
DCs in all tissues showed enhanced transcription of genescoding molecules involved in TGF-b1 activation including the
following: furin (Dubois et al., 1995) andmatrix metalloproteinase
9 (MMP-9) (Yu and Stamenkovic, 2000), involved in proteolytic
cleavage of TGF-b1; CD36, a coreceptor involved in the interac-
tion with thrombospondin-1 (Crawford et al., 1998; Silverstein
et al., 1992; Wang et al., 2009, 2010); and PLAUR, urokinase
plasminogen activator (CD87) that contributes to TGF-b1 activa-
tion in myeloid cells (Goda´r et al., 1999) (Figure 6D). The unique
expression of CD36 and PLAUR by CD1c+ DCs was further
confirmed by flow cytometry (Figure 6E).
Consistent with the above finding, TGF-b neutralizing anti-
bodies substantially reduced the ability of CD1c+ DCs to induce
CD103 expression on CD8+ T cells in vitro (Figure 7A). The gen-
eration of CD103+CD8+ T cells by CD1c+ DCs purified from the
lungs of humanized mice (Figure 7B) and humans (Figure 7C)Immunity 38, 818–830, April 18, 2013 ª2013 Elsevier Inc. 825
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Figure 7. Human Lung CD1c+ DCs Expand CD103+CD8+ T Cells via TGF-b
Sorted DCs were cocultured with CFSE-labeled allogeneic naive T cells at a 1:100 ratio in the presence or absence of TGF-b Ab blockade as indicated. At day 6,
CFSECD8+ T cells were analyzed for CD103 expression by flow cytometry.
(A) Representative scatterplots showing CD103 expression on CFSECD8+ T cells cocultured with CD1c+ DCs in the presence of 100 mg/ml of TGF-b neutralizing
Abs or isotype control.
(B–E) Percentages of CD103-expressing CFSECD8+ T cells and percentages of CFSECD8+ total T cells in cocultures with DC subsets isolated from the lungs of
humanizedmice (B) human lungs (C) in the presence of titrated doses of TGF-b neutralizing Abs or TGF-bRI kinase inhibitor (D). One representative experiment of
more than three is shown (one-way ANOVA with Bonferroni post-test). Data are shown as mean ± SEM.
(E) The same type of experiment as in (B) but DCs are sorted from the draining LNs of humanized mice.
(F) Scatterplots illustrated CD103 expression on CFSECD8+ T cells cocultured with CD141+ DCs in the presence of recombinant human TGF-b1.
Immunity
CD1c+ DCs Expand Mucosal CD8+ T Cellswas reproducibly blocked in a dose-dependent manner by
TGF-b neutralizing antibodies, and nearly complete inhibition
was observed at a dose of 100 mg/mL (Figure 7D). TGF-b-depen-
dent expression of CD103 was observed in the experiments that
used DCs sorted from the lungs and lung-draining LNs of
humanized mice as well as human lungs (Figures 7B–7E). The
involvement of TGF-b was further confirmed by the pharmaco-
logical blockade of TGF-b by using TGF-b RI kinase inhibitor II
(Ito et al., 2008) in DC-T cocultures (Figure 7D). Inhibition of
CD103 expression was not associated with the global inhibition
of T cell proliferation as shown in Figures 7B–7E. Conversely,
adding human recombinant TGF-b1 in cocultures of allogeneic
naive T cells with CD141+ DCs led to dose-dependent expansion826 Immunity 38, 818–830, April 18, 2013 ª2013 Elsevier Inc.of CD103-expressing CD8+ T cells (Figure 7F). This, together
with transcriptional profile analysis, suggests that the inability
of CD141+ DCs to drive CD103 expression on CD8+ T cells might
simply reflect their inability to present and activate TGF-b1. Alto-
gether, these results establish that the unique ability of CD1c+
DCs to present membrane-bound TGF-b1 to CD8+ T cells con-
tributes to their superior ability to promote the differentiation of
CD103+CD8+ T cells and contribute to mucosal immunity.
DISCUSSION
DCs are composed of subsets that differ in their localization,
phenotype, and functions. This appears to provide a critical
Immunity
CD1c+ DCs Expand Mucosal CD8+ T Cellspath for the generation andmaintenance of a highly diverse func-
tional T cell repertoire including for example Th1, Th2, Th17, and
Treg cells. However, the contribution of the distinct human DC
subsets to this extensive functional T cell repertoire in vivo is
not fully understood, particularly as it relates to the generation
of cytotoxic effector CD8+ T cells. In our humanized mouse
model, intranasal vaccination with LAIV demonstrated that
CD11c+CD14CD303 DCs are able to present viral antigens
to CD8+ T cells. Because CD11c+CD14CD303 DCs consist
of two subsets that include CD1c+ and CD141+ DCs (Haniffa
et al., 2012), the goal of the current study was to determine the
contribution of CD1c+ and CD141+ DC subsets to the quality of
the antiviral CD8+ T cell response.
The results show that human CD1c+ DCs, but not CD141+ DCs
isolated from humanized mouse lungs and human lung explants,
drive the differentiation of both naive and memory CD8+ T cells
into CD8+ T cells expressing CD103. CD103 forms a heterodimer
with the integrin b7, allowing peripheral CD8+ T cells to access
the epithelial compartments (Shaw and Brenner, 1995; Sheridan
and Lefranc¸ois, 2011). CD103 specifically binds E-cadherin that
is expressed on murine and human epithelial cells (Agace et al.,
2000; Scho¨n et al., 1999). The expression of CD103 by CD8+
T cells allows for the retention of CD8+ T cell in the lungs in
mice (Lee et al., 2011) and humans (Piet et al., 2011). Although
lung-tissue-resident memory CD103+CD8+ T cells do not consti-
tutively express perforin or granzyme B, they can rapidly upregu-
late these cytotoxic molecules upon TCR engagement (Smyth
et al., 2007). The current study further established that CD1c+
DCs were uniquely able to induce the expression of CD103 on
activated CD8+ T cells and enable their adherence to lung tissue
sections ex vivo, as well as their accumulation in vivo in a cell bed
composed of human lung epithelial cell lines that are engrafted
into immunodeficient mice. Following acute infection, microbe-
specific memory CD8+ T cells persist in the blood while accumu-
lating in nonlymphoid tissues, where their numbers may actually
exceed those in circulation (Sheridan and Lefranc¸ois, 2011).
These tissue-resident memory T cells can be superior to circu-
lating central memory T cells at providing rapid protection
against reinfection in mice (Gebhardt et al., 2009; Liu et al.,
2010) and humans (Clark et al., 2012). Therefore, an activemech-
anism of T cell retention in the periphery likely exists not only to
facilitate the clearance of infected cells but also to promote the
accumulation of CD8+ T cells in sites where it is appropriate to
prevent reinfection. Our results suggest that CD1c+ DCs in the
mucosal sites might represent the master regulator of CD103
expression on CD8+ T cells thereby controlling their accumula-
tion in the tissue.
The expression of CD103 on CD8+ T cells appears to mostly
depend upon TGF-b1 (Parker et al., 1992; Rihs et al., 1996).
Graft-versus-host disease with mice engineered to lack TGF-b
receptor signaling demonstrated that the effector CD8+ T cells
infiltrating the intestinal epithelium did not express CD103 and
showed a lower pathogenic potential (El-Asady et al., 2005).
Therefore, our demonstration that human CD1c+ DCs utilize
membrane-bound TGF-b1 to drive CD103 expression on prolif-
erating CD8+ T cells, both in the allogeneic and autologous influ-
enza-specific T cell responses, expands these data to the human
setting. Indeed, flow cytometry analysis revealed that CD1c+
DCs but not CD141+ DCs express membrane TGF-b1 despitethe fact that both subsets express transcripts involved in the pro-
duction of TGF-b1. Interestingly, transcriptional profiling of DC
subsets revealed that CD1c+ DCs in steady state display an array
of transcripts coding molecules involved in the activation and
cleavage of latent TGF-b1 in humans. These include furin and
MMP9 and several molecules interacting with TSP-1 including
CD36 (Crawford et al., 1998; Silverstein et al., 1992; Wang
et al., 2009, 2010). CD36 binds TSP-1, which then binds latent
TGF-b1 (Yehualaeshet et al., 2000). The lack of CD36 might
explain why CD141+ DCs are less potent at driving CD103
expression onCD8+ T cells despite the local availability of human
TGF-b1 stored in extracellular matrix or available in the serum.
These unique molecular portraits of CD1c+ and CD141+ DCs
are preserved across different tissues in both humans and
humanized mice thereby suggesting that the capacity to
regulate CD103 expression on CD8+ T cells represents an
intrinsic feature of CD1c+ DCs rather than imprinting by tissue
microenvironment.
Our results show that both CD1c+ DCs and CD141+ DCs are
capable of influenza vaccine antigen presentation and that
each subset generates CD8+ T cells with unique phenotypic
and functional properties. These results further our understand-
ing of the functional specializations of human DC subsets and
their underlyingmolecular mechanisms. Earlier studies of human
cutaneous DCs have demonstrated their phenotypic and func-
tional heterogeneity (Morelli et al., 2005; Nestle et al., 1993;
Valladeau and Saeland, 2005; Zaba et al., 2007). Our studies
with human LCs and interstitial DCs concluded their specializa-
tion in priming CD8+ T cell immunity and humoral immunity,
respectively (Caux et al., 1997; Klechevsky et al., 2008). They
stressed the role of IL-15 in the priming of cytotoxic effectors
and the role of interstitial DC-derived IL-12 in the priming of
follicular helper T cells (Schmitt et al., 2009) and in the differenti-
ation of plasma cells (Dubois et al., 1998). Recent studies have
analyzed lymph-node-resident and skin-migratory DC subsets
in humans (Chu et al., 2012; Haniffa et al., 2012; Segura et al.,
2012). Both CD1c+ and CLEC9A-expressing CD141+ DCs iso-
lated from human LNs were able to cross-present long peptides
(requiring processing) and short peptides of melanoma-tissue-
derived antigen (MART-1) to T cell lines (Segura et al., 2012). In
agreement with earlier observations, blood DC subsets required
activation via Toll-like receptor ligands to cross-present long
peptides (Crozat et al., 2010; Jongbloed et al., 2010). Our results
described herein bring a unique perspective to the specialization
of human DC subsets and reveal a function for the CD1c+ DC
subset in driving peripheral T cell homeostasis in the steady state
and after vaccination with attenuated virus. These results have
implications for the design of novel vaccines aimed at promoting
long-lived T cell immunity at epithelial interfaces. Furthermore,
they strengthen the rationale for targeting specific DC subsets
to generate desired types of immune responses.
EXPERIMENTAL PROCEDURES
DC Purification
Humanized mice were generated on NOD-SCID B2m/ mice background as
previously described (Yu et al., 2008). All protocols were approved by the
Institutional Review Board (IRB, 097-053 and 099-076) and the Institutional
Animal Care and Use Committee (A01-005) at Baylor Research Institute.
At 4 weeks posttransplant, humanized mice were either mock inoculatedImmunity 38, 818–830, April 18, 2013 ª2013 Elsevier Inc. 827
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CD1c+ DCs Expand Mucosal CD8+ T Cellswith PBS or vaccinatedwith LAIV (1/5 of human dose) via intranasal inoculation
and harvested according to the experimental design. After flushing out the
blood, the lungs were processed to prepare single-cell suspensions: they
were digested with 2 mg/mL collagenase D (Roche Diagnostics, Indianapolis,
IN) for 30min at 37C; suspensions weremade and the debris was removed by
filtering through a 70 mm cell strainer. Spleens and LNs were digested for
30 min by using the same method. Cells were first treated with murine and hu-
man Fc blocker and then stained on icewith fluorochrome-conjugated specific
Abs. DCs were sorted with FACSAria by using Diva software (BD). Detailed
antibodies and reagents were provided in the Supplemental Information.
Human lung tissues were obtained from consenting patients undergoing
lung resection surgery at The Mount Sinai Medical Center (New York, NY).
Tissues were taken from noninvolved lung areas in patients with pulmonary
resection surgeries for either pulmonary metastatic disease or primary non-
small-cell lung cancer. All protocols were approved by IRB (08-1236-
000108-1236-0005) at MSSM. Care was taken to obtain lung tissue as
distant as possible from any primary lesions and anatomic abnormalities
and in a way to proportionally represent subpleural (distal) and deeper (prox-
imal) anatomic regions of lung. Human lung tissue was processed analogously
to the humanizedmice protocol. Alternatively, DCswere first enriched by using
human Pan-DC Pre-Enrichment Kit (StemCell Technologies) before staining
for cell sorting by flow cytometry.
PBMCs were isolated from leukapheresis products using Ficoll-Paque Plus
density gradient centrifugation (StemCell Technologies, Vancouver, Canada).
DCs were first enriched by using human Pan-DC Pre-Enrichment Kit before
staining for cell-sorting by flow cytometry.
Autologous T Cell Assay
CD8+ T cells or total T cells were isolated from PBMCs autologous to CD34+
HPCs by using human T cell enrichment kits (StemCell Technologies) following
the manufacturer’s protocol. Isolated CD8+ T cells or total T cells had a purity
of >95%. T cells were labeled with 1 mM CFSE (Invitrogen) for 10 min at room
temperature and cocultured with sorted DCs for 8 days in complete RPMI with
10% AB serum. Samples were stained with fluorochrome-conjugated Abs for
surface markers and APC-conjugated FluM1 or NS1-HLA-A*0201 tetramer at
room temperature for 30 min, acquired on an LSRII (BD), and analyzed with
FlowJo software (Tree Star, Ashland, OR). In experiments with in vitro loading,
sorted CD1c+ and CD141+ DC subsets were loaded with LAIV (moi = 2) for 1 hr
before cultured with T cells.
Allogeneic Mixed Lymphocyte Reaction
Naive T cells were isolated from PBMCs of healthy volunteers by using human
naive T cell enrichment kits (StemCell Technologies) and further sorted for
CD45RA+CCR7+ T cells (>99% purity). CFSE-labeled naive T cells (100,000
cells) were cocultured with sorted DCs for 6 days. In TGF-b blocking ex-
periments, DCs were first treated with anti-TGF-b antibodies (1D11, R&D
Systems) for 30 min at 37C, and TGF-b RI kinase inhibitor II was added in
the beginning of the coculture.
Microarrays
Total RNA was extracted by using the RNAqueous-Micro Kit (Life Technolo-
gies). Biotinylated, amplified cRNA targets were then prepared, hybridized
to Illumina Human HT-12 V4 BeadChips, and scanned following the manufac-
turer’s instructions (Illumina). GenomeStudio (Illumina) was then used to
perform quality control, generate signal intensity values, and perform normal-
ization by subtracting background and scaling average signal intensity for
each sample to the global average signal intensity for all samples. Scaled
and background subtracted data were analyzed by using GeneSpring GX v
7.3.1 (Agilent Technologies). All signal values <10 were then set to a threshold
level of 10. Next, per-gene normalization to the median intensity of all the
samples was applied. Probes were filtered by ‘‘present’’ call requiring signal
intensity detection p value less than 0.01 in at least one of all the samples
for each tissue type. Raw microarray data has been deposited with GEO
(accession number GSE43184).
Stamper-Woodruff Binding Assay
The technique was modified from previous reports. We added 20,000 CFSE-
labeled CD8+ T cells in 200 ml to the frozen human lung sections that were828 Immunity 38, 818–830, April 18, 2013 ª2013 Elsevier Inc.acetone fixed and rinsed previously. T cells were allowed to settle for 1 hr at
37C, and unbound cells were subsequently removed by extensive washing
with PBS. The sections were then further fixed with 4% paraformaldehyde
and stained with anti-cytokeratin-Alexa Fluor 568. Each experiment used
sections from a single human lung by using sequential sections. If antibody
blocking was performed, T cells were preincubated with 20 mg/ml of
anti-CD103 Abs or isotype control for 30 min before adding to the tissue
sections. The binding capacity of T cells was measured by the numbers of
CFSE+ cells in a 0.1 mm2 cytokeratin+ epithelial area by using a fluorescence
microscope (Olympus, Japan) with MetaMorph software (Molecular Devices,
Sunnyvale, CA).
In Vivo Human Lung Graft Experiment
H1650 (ATCC) human lung cancer cells (10 3 106) were harvested from
cultures and injected subcutaneously into the flanks of sublethally irradiated
NOD/SCID IL-2Rg chain/ mice. At day 3, CFSE-labeled CD8+ T cells were
injected directly into human epithelial grafts and analyzed 3 days later for
the presence of T cells by flow cytometry. If Ab blocking was performed,
T cells in the human epithelial grafts were treated daily with 50 mg of anti-
CD103 Abs or isotype control. In some experiments, both sorted DCs
(3 3 105) and CFSE-labeled naive T cells (3 3 106) were injected into human
epithelial grafts, and the T cell phenotypes were analyzed at day 6.
Statistical Analysis
Nonparametric tests were used for all group analyses. Differences in variables
between any two groups were analyzed by using the Mann-Whitney U test or
two-tailed t test. Differences between any three or more groups were analyzed
by ANOVA. Two-way ANOVA with Bonferroni post-tests was used to compare
data with two variances. All statistics and graphs were done with Prism
software (GraphPad, La Jolla, CA).
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